Ad
related to: hib vaccine names list pdf
Search results
Results From The WOW.Com Content Network
Hib conjugate vaccines are effective against all manifestations of Hib disease, with a clinical efficacy among fully vaccinated children estimated to be between 95–100%. The vaccine has also been shown to be immunogenic in patients at high risk of invasive disease. Hib vaccine is not effective against non-type B Haemophilus influenzae.
DTaP-IPV/Hib vaccine is a 5-in-1 combination vaccine that protects against diphtheria, tetanus, whooping cough, polio, and Haemophilus influenzae type B. [1] [2]Its generic name is "diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and haemophilus B conjugate vaccine", and it is also known as DTaP-IPV-Hib.
DTwP-HepB-Hib vaccine is a 5-in-1 combination vaccine with five individual vaccines conjugated into one. [1] It protects against diphtheria , tetanus , whooping cough , hepatitis B and Haemophilus influenzae type B , [ 1 ] which is generally used in middle- and low-income countries , where polio vaccine is given separately.
Vaccine Excipients Adenovirus vaccine: This list refers to the type 4 and type 7 adenovirus vaccine tablets licensed in the US: Acetone, alcohol, anhydrous lactose, castor oil, cellulose acetate phthalate, dextrose, D-fructose, D-mannose, FD&C Yellow #6 aluminium lake dye, fetal bovine serum, human serum albumin, magnesium stearate, micro crystalline cellulose, plasdone C, Polacrilin potassium ...
DTaP-Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed with Haemophilus B conjugate vaccine, sometimes abbreviated to DTaP-Hib. [2] It protects against the infectious diseases diphtheria, tetanus, pertussis, and Haemophilus influenzae type B. [3] [4]
Hib vaccines cost about seven times the total cost of vaccines against measles, polio, tuberculosis, diphtheria, tetanus, and pertussis. Consequently, whereas 92% of the populations of developed countries were vaccinated against Hib as of 2003, vaccination coverage was 42% for developing countries, and only 8% for least-developed countries.
A pentavalent vaccine combines five vaccines into one dose. Pentavalent vaccines include: DTwP-HepB-Hib vaccine, used by UNICEF in low/middle income countries; DTaP-IPV/Hib vaccine, used in the UK until 2017 (replaced by a hexavalent vaccine) DTaP-IPV-HepB vaccine, approved in the US
Kinrix (for diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine) Menhibrix (meningococcal groups C and Y and haemophilus b tetanus toxoid conjugate vaccine) Menitorix (combined Haemophilus influenzae type b and Neisseria meningitidis group C (Hib-MenC) conjugate vaccines) Menjugate (for meningitis C)